INDOLENT LYMPHOMA

Clinical trials for INDOLENT LYMPHOMA explained in plain language.

Never miss a new study

Get alerted when new INDOLENT LYMPHOMA trials appear

Sign up with your email to follow new studies for INDOLENT LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 2 Not yet finished but already full! 1

Experimental 'Natural Killer' cell therapy takes on tough blood cancers

Disease control Ongoing

This early-phase study tests an experimental therapy called NKX019, made from donor immune cells (natural killer cells) engineered to target and kill cancer cells. It is for people with certain blood cancers (like lymphoma or leukemia) that have come back or not responded to othe…

Matched conditions: INDOLENT LYMPHOMA

Phase: PHASE1 • Sponsor: Nkarta, Inc. • Aim: Disease control

Last updated May 05, 2026 11:54 UTC

INDOLENT LYMPHOMA

Get alerted when new INDOLENT LYMPHOMA trials appear

Experimental 'Natural Killer' cell therapy takes on tough blood cancers